Follow
Ines Baldeiras
Ines Baldeiras
Verified email at fmed.uc.pt
Title
Cited by
Cited by
Year
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
14912015
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
3972013
Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease
I Baldeiras, I Santana, MT Proença, MH Garrucho, R Pascoal, ...
Journal of Alzheimer's Disease 15 (1), 117-128, 2008
1962008
Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease
SI Mota, RO Costa, IL Ferreira, I Santana, GL Caldeira, C Padovano, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (7 …, 2015
1872015
Mitochondrial-and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers
E Ferreiro, I Baldeiras, IL Ferreira, RO Costa, AC Rego, CF Pereira, ...
International Journal of Cell Biology 2012, 2012
1802012
Metabolic alterations induced by sucrose intake and Alzheimer’s disease promote similar brain mitochondrial abnormalities
C Carvalho, S Cardoso, SC Correia, RX Santos, MS Santos, I Baldeiras, ...
Diabetes 61 (5), 1234-1242, 2012
1712012
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
1662018
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
AH Simonsen, SK Herukka, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 274-284, 2017
1632017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
SK Herukka, AH Simonsen, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 285-295, 2017
1482017
Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet
MV Machado, P Ravasco, L Jesus, P Marques-Vidal, CR Oliveira, ...
Scandinavian journal of gastroenterology 43 (1), 95-102, 2008
1292008
Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation
MR Almeida, MC Macário, L Ramos, I Baldeiras, MH Ribeiro, I Santana
Neurobiology of aging 41, 200. e1-200. e5, 2016
1142016
Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic
M Schmitz, E Ebert, K Stoeck, A Karch, S Collins, M Calero, T Sklaviadis, ...
Molecular neurobiology 53, 2189-2199, 2016
1122016
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
IS van Maurik, SJ Vos, I Bos, FH Bouwman, CE Teunissen, P Scheltens, ...
The Lancet Neurology 18 (11), 1034-1044, 2019
1072019
Insulin-induced recurrent hypoglycemia exacerbates diabetic brain mitochondrial dysfunction and oxidative imbalance
S Cardoso, RX Santos, SC Correia, C Carvalho, MS Santos, I Baldeiras, ...
Neurobiology of disease 49, 1-12, 2013
1052013
Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment
I Baldeiras, I Santana, MT Proença, MH Garrucho, R Pascoal, ...
Journal of Alzheimer's disease 21 (4), 1165-1177, 2010
1002010
Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
I Baldeiras, I Santana, MJ Leitão, H Gens, R Pascoal, M Tábuas-Pereira, ...
Alzheimer's research & therapy 10, 1-15, 2018
902018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
N Mattsson, C Groot, WJ Jansen, SM Landau, VL Villemagne, ...
Alzheimer's & Dementia 14 (7), 913-924, 2018
792018
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients
IE Baldeiras, MH Ribeiro, P Pacheco, A Machado, I Santana, L Cunha, ...
Journal of neurology 256, 1540-1550, 2009
772009
Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases
I Zerr, M Schmitz, A Karch, A Villar-Piqué, E Kanata, E Golanska, ...
Alzheimer's & Dementia 14 (6), 751-763, 2018
732018
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
F Llorens, P Hermann, A Villar-Piqué, D Diaz-Lucena, K Nägga, ...
Nature communications 11 (1), 619, 2020
692020
The system can't perform the operation now. Try again later.
Articles 1–20